OHDSI Home | Forums | Wiki | Github

Phenotype Submission - Pulmonary Hypertension

Cohort Definition Name: “Pulmonary Hypertension”
Contributor name: Joel N. Swerdel
Contributor OrcId: 0000-0001-9491-2737
Logic Description: First occurrence of Pulmonary Hypertension.
Recommended study application: outcome, indication
Assertion statement: This cohort definition was executed on at least one real person-level observational health data source and resulted in a cohort with at least 1 person.
Submitted cohort definition:
Pulmonary Hypertension.txt (1.3 KB)

Target Clinical Description

Pulmonary hypertension is a condition characterized by high blood pressure in the pulmonary arteries, which are the blood vessels that carry blood from the heart to the lungs. This elevated pressure puts strain on the right side of the heart as it works harder to pump blood into the lungs. Pulmonary hypertension can be classified into different groups based on the underlying cause and pathophysiology, and it can lead to symptoms such as shortness of breath, fatigue, chest pain, and eventually heart failure if left untreated.

Presentation for Pulmonary Hypertension:

  • Shortness of breath, especially during physical activity

  • Fatigue and weakness

  • Chest pain or discomfort

  • Rapid or irregular heartbeat (palpitations)

  • Dizziness or fainting spells

  • Swelling in the ankles, legs, or abdomen (edema)

  • Bluish lips or skin (cyanosis)

  • Coughing up blood (hemoptysis)

  • Reduced exercise tolerance

  • Distended neck veins

Assessment for Pulmonary Hypertension:

  • Medical history and physical examination to assess symptoms, identify risk factors, and evaluate signs of heart failure or underlying diseases.

  • Echocardiogram to evaluate heart structure and function, measure pulmonary artery pressure, and assess the severity of pulmonary hypertension.

  • Electrocardiogram (ECG) to assess heart rhythm and detect any signs of right ventricular strain.

  • Pulmonary function tests to evaluate lung function and determine if an underlying lung disease is contributing to pulmonary hypertension.

  • Blood tests to check for specific biomarkers, assess oxygen levels, and identify potential underlying causes.

  • Right heart catheterization to directly measure pulmonary artery pressure and assess the response to vasodilator medications.

Differential diagnoses for Pulmonary Hypertension:

  • Left heart failure: Left-sided heart failure can lead to elevated pulmonary pressures and mimic symptoms of pulmonary hypertension.

  • Chronic lung diseases: Conditions such as chronic obstructive pulmonary disease (COPD) or interstitial lung disease can cause pulmonary hypertension due to impaired lung function.

  • Pulmonary embolism: Blood clots in the pulmonary arteries can acutely increase pulmonary pressure and present with similar symptoms to pulmonary hypertension.

  • Connective tissue diseases: Autoimmune disorders like systemic sclerosis or lupus can be associated with pulmonary hypertension.

  • Congenital heart diseases: Certain congenital heart defects, such as atrial septal defect or Eisenmenger syndrome, can result in pulmonary hypertension.

Treatment plan for Pulmonary Hypertension:

  • Medications: Prescribing vasodilators, such as calcium channel blockers, endothelin receptor antagonists, prostacyclin analogs, or phosphodiesterase-5 inhibitors, to relax and widen the blood vessels in the lungs, reducing pulmonary artery pressure.

  • Oxygen therapy: Administering supplemental oxygen to improve oxygenation and relieve symptoms of shortness of breath.

  • Diuretics: Prescribing diuretic medications to reduce fluid retention and decrease the workload on the heart.

  • Anticoagulants: Using blood-thinning medications to prevent blood clots from forming and worsening pulmonary hypertension.

  • Supportive measures: Recommending lifestyle modifications, such as regular exercise, a healthy diet, smoking cessation, and avoiding high altitudes or situations that worsen symptoms.

  • Pulmonary rehabilitation: Referring individuals to pulmonary rehabilitation programs to improve exercise capacity, provide education on managing symptoms, and enhance quality of life.

  • Surgical interventions: In severe cases or when medications fail to control symptoms, lung transplantation or atrial septostomy (creating an opening between the right and left atria) may be considered.

Prognosis for Pulmonary Hypertension:

The prognosis of pulmonary hypertension varies depending on the underlying cause, the severity of the condition, and the individual’s response to treatment. Early diagnosis and appropriate management can significantly improve outcomes and slow disease progression. However, in advanced stages or when left untreated, pulmonary hypertension can lead to right heart failure and significantly reduce life expectancy. Regular follow-up care, adherence to treatment plans, and close monitoring are essential to optimize outcomes and improve the quality of life for individuals with pulmonary hypertension.

Hi @jswerdel thank you. Imported with id 744

t